Prowling wolves in sheep's clothing: The search for tumor stem cells

Biological Chemistry

Volumn 389, Issue 7, 2008, Pages 799-811

  Alkatout, Ibrahim ^a   Kabelitz, Dieter ^a   Kalthoff, Holger ^a   Tiwari, Sanjay ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

CD133; Dormancy; In vivo imaging; Metastases; Niche; Tumor initiating cells

Indexed keywords

ALDEHYDE DEHYDROGENASE; BETA1 INTEGRIN; CD133 ANTIGEN; CD24 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; COLLAGEN TYPE 4; GRANULOCYTE COLONY STIMULATING FACTOR; HERMES ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE P38; NESTIN; RAF PROTEIN; STROMAL CELL DERIVED FACTOR 1;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; BREAST METASTASIS; CANCER CELL CULTURE; CANCER STEM CELL; CELL DEATH; CELL FATE; CELL RENEWAL; DISEASE MARKER; ENGRAFTMENT; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC POLYMORPHISM; GRAFT VERSUS LEUKEMIA EFFECT; HEAD AND NECK CANCER; HEMATOPOIESIS; HUMAN; IMMUNOPHENOTYPING; IN VIVO STUDY; MALIGNANT TRANSFORMATION; MULTIPOTENT STEM CELL; NEAR INFRARED SPECTROSCOPY; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN VARIANT; REVIEW; SCID MOUSE; SOMATIC MUTATION; TRANSGENIC MOUSE; TUMOR PROMOTION; XENOGRAFT;

ANIMALS; HUMANS; IMMUNE SYSTEM; NEOPLASMS; NEOPLASTIC STEM CELLS; TUMOR MARKERS, BIOLOGICAL;

CANIDAE; OVIS ARIES;

EID: 49149098126     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2008.094     Document Type: Review

References (133)

1. Acton, P.D. and Zhou, R. (2005). Imaging reporter genes for cell tracking with PET and SPECT. Q.J. Nucl. Med. Mol. Imaging 49, 349-360.
2. Aguirre-Ghiso, J.A. (2007). Models, mechanisms and clinical evidence for cancer dormancy. Nat. Rev. Cancer 7, 834-846.
3. Aguirre-Ghiso, J.A., Kovalski, K., and Ossowski, L. (1999). Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. J. Cell Biol. 147, 89-104.
4. Aguirre-Ghiso, J.A., Ossowski, L., and Rosenbaum, S.K. (2004). Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth. Cancer Res. 64, 7336-7345.
5. Al-Hajj, M. and Clarke, M.F. (2004). Self-renewal and solid tumor stem cells. Oncogene 23, 7274-7282.
6. Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J., and Clarke, M.F. (2003). Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100, 3983-3988.
7. Allan, A.L., Vantyghem, S.A., Tuck, A.B., and Chambers, A.F. (2006). Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis. Breast Dis. 26, 87-98.
8. Amado, L.C., Saliaris, A.P., Schuleri, K.H., St. John, M., Xie, J.S., Cattaneo, S., Durand, D.J., Fitton, T., Kuang, J.Q., Stewart, G., et al. (2005). Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc. Natl. Acad. Sci. USA 102, 11474-11479.
9. Auerbach, R. (1988). Patterns of tumor metastases: organ selectivity in the spread of cancer cells. Lab. Invest. 58, 361-364.
10. + stem/progenitor cells to bone marrow. Blood 103, 2981-2989.
11. Bao, S., Wu, Q., McLendon, R.E., Hao, Y., Shi, Q., Hjelmeland, A.B., Dewhirst, M.W., Bigner, D.D., and Rich, J.N. (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756-760.
12. Barnhart, B.C. and Simon, M.C. (2007). Metastasis and stem cell pathways. Cancer Metastasis Rev. 26, 261-271.
13. Ben-Baruch, A. (2006). Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. Semin. Cancer Biol. 16, 38-52.
14. Bernards, R. and Weinberg, R.A. (2002). A progression puzzle. Nature 418, 823.
15. Bleakley, M. and Riddell, S.R. (2004). Molecules and mechanisms of the graft-versus-leukaemia effect. Nat. Rev. Cancer 4, 371-380.
16. Calabrese, C., Poppleton, H., Kocak, M., Hogg, T.L., Fuller, C., Hamner, B., Oh, E.Y., Gaber, M.W., Finklestein, D., Allen, M., et al. (2007). A perivascular niche for brain tumor stem cells. Cancer Cell 11, 69-82.
17. Cameron, M.D., Schmidt, E.E., Kerkvliet, N., Nadkarni, K.V., Morris, V.L., Groom, A.C., Chambers, A.F., and MacDonald, I.C. (2000). Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Res. 60, 2541-2546.
18. Cao, Y.A., Wagers, A.J., Beilhack, A., Dusich, J., Bachmann, M.H., Negrin, R.S., Weissman, I.L., and Contag, C.H. (2004). Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc. Natl. Acad. Sci. USA 101, 221-226.
19. - medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity. Eur. J. Immunol. 37, 3190-3196.
20. Chambers, A.F., Groom, A.C., and MacDonald, I.C. (2002). Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2, 563-572.
21. Cohen, B., Dafni, H., Meir, G., Harmelin, A., and Neeman, M. (2005). Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia 7, 109-117.
22. Cohnheim, V. (1875). Congenitales, quergestreiftes muskelsarkom der nieren. Virchow's Arch. Pathol. Anat. Physiol. Klin. Med. 65, 64-69.
23. Collins, A.T., Berry, P.A., Hyde, C., Stower, M.J., and Maitland, N.J. (2005). Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65, 10946-10951.
24. Dalerba, P., Dylla, S.J., Park, I.K., Liu, R., Wang, X., Cho, R.W., Hoey, T., Gurney, A., Huang, E.H., Simeone, D.M., et al. (2007). Phenotypic characterization of human colorectal cancer stem cells. Proc. Natl. Acad. Sci. USA 104, 10158-10163.
25. Danchakoff, A. (1916). Origin of blood cells. Development of the haematopoietic organs and regeneration of the blood cells from the standpoint of the monophyletic school. Anat. Rec. 10, 397-414.
26. de Rijke, B., van Horssen-Zoetbrood, A., Beekman, J.M., Otterud, B., Maas, F., Woestenenk, R., Kester, M., Leppert, M., Schattenberg, A.V., de Witte, T., et al. (2005). A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia. J. Clin. Invest. 115, 3506-3516.
27. Demicheli, R. (2001). Tumour dormancy: findings and hypotheses from clinical research on breast cancer. Semin. Cancer Biol. 11, 297-306.
28. Diehn, M. and Clarke, M.F. (2006). Cancer stem cells and radiotherapy: new insights into tumor radioresistance. J. Natl. Cancer Inst. 98, 1755-1757.
29. Donato, R. (2001). S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33, 637-668.
30. Fidler, I.J. (1991). Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of metastasis. Cancer Metastasis Rev. 10, 229-243.
31. Frangioni, J.V. (2003). In vivo near-infrared fluorescence imaging. Curr. Opin. Chem. Biol. 7, 626-634.
32. Frank, N.Y., Margaryan, A., Huang, Y., Schatton, T., Waaga-Gasser, A.M., Gasser, M., Sayegh, M.H., Sadee, W., and Frank, M.H. (2005). ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res. 65, 4320-4333.
33. Frankenberger, B., Noessner, E., and Schendel, D.J. (2007). Immune suppression in renal cell carcinoma. Semin. Cancer Biol. 17, 330-343.
34. Ginestier, C., Hur, M.H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C.G., Liu, S., et al. (2007). ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1, 555-567.
35. Glunde, K., Pathak, A.P., and Bhujwalla, Z.M. (2007). Molecular-functional imaging of cancer: to image and imagine. Trends Mol. Med. 13, 287-297.
36. Gupta, P.B., Kuperwasser, C., Brunet, J.P., Ramaswamy, S., Kuo, W.L., Gray, J.W., Naber, S.P., and Weinberg, R.A. (2005). The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nat. Genet. 37, 1047-1054.
37. Hermann, P.C., Huber, S.L., Herrler, T., Aicher, A., Ellwart, J.W., Guba, M., Bruns, C.J., and Heeschen, C. (2007). Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cancer Stem Cell 1, 313-323.
38. Hill, R.P. and Perris, R. (2007).'Destemming' cancer stem cells. J. Natl. Cancer Inst. 99, 1435-1440.
39. Hill, R.P., Chambers, A.F., Ling, V., and Harris, J.F. (1984). Dynamic heterogeneity: rapid generation of metastatic variants in mouse B16 melanoma cells. Science 224, 998-1001.
40. Hinz, S., Pagerols-Raluy, L., Oberg, H.H., Ammerpohl, O., Grussel, S., Sipos, B., Grutzmann, R., Pilarsky, C., Ungefroren, H., Saeger, H.D., et al. (2007). Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. Cancer Res. 67, 8344-8350.
41. Hiratsuka, S., Watanabe, A., Aburatani, H., and Maru, Y. (2006). Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat. Cell Biol. 8, 1369-1375.
42. Hoehn, M., Kustermann, E., Blunk, J., Wiedermann, D., Trapp, T., Wecker, S., Focking, M., Arnold, H., Hescheler, J., Fleischmann, B.K., et al. (2002). Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc. Natl. Acad. Sci. USA 99, 16267-16272.
43. Hope, K.J., Jin, L., and Dick, J.E. (2004). Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat. Immunol. 5, 738-743.
44. Hoshino, K., Ly, H.Q., Frangioni, J.V., and Hajjar, R.J. (2007). In vivo tracking in cardiac stem cell-based therapy. Prog. Cardiovasc. Dis. 49, 414-420.
45. Jager, D., Taverna, C., Zippelius, A., and Knuth, A. (2004). Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloning. Cancer Immunol. Immunother. 53, 144-147.
46. Jin, L., Hope, K.J., Zhai, Q., Smadja-Joffe, F., and Dick, J.E. (2006). Targeting of CD44 eradicates human acute myeloid leukemia stem cells. Nat. Med. 12, 1167-1174.
47. John, A. and Tuszynski, G. (2001). The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol. Oncol. Res. 7, 14-23.
48. Josephson, L., Tung, C.H., Moore, A., and Weissleder, R. (1999). High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug. Chem. 10, 186-191.
49. Kang, Y. (2005). Functional genomic analysis of cancer metastasis: biologic insights and clinical implications. Expert Rev. Mol. Diagn. 5, 385-395.
50. Kang, Y., He, W., Tulley, S., Gupta, G.P., Serganova, I., Chen, C.R., Manova-Todorova, K., Blasberg, R., Gerald, W.L., and Massague, J. (2005). Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc. Natl. Acad. Sci. USA 102, 13909-13914.
51. Kaplan, R.N., Riba, R.D., Zacharoulis, S., Bramley, A.H., Vincent, L., Costa, C., MacDonald, D.D., Jin, D.K., Shido, K., Kerns, S.A., et al. (2005). VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438, 820-827.
52. Kaplan, R.N., Rafii, S., and Lyden, D. (2006). Preparing the 'soil': the premetastatic niche. Cancer Res. 66, 11089-11093.
53. Karrison, T.G., Ferguson, D.J., and Meier, P. (1999). Dormancy of mammary carcinoma after mastectomy. J. Natl. Cancer Inst. 91, 80-85.
54. Kawasaki, B.T., Mistree, T., Hurt, E.M., Kalathur, M., and Farrar, W.L. (2007). Co-expression of the toleragenic glycoprotein, CD200, with markers for cancer stem cells. Biochem. Biophys. Res. Commun. 364, 778-782.
55. Kelloff, G.J., Krohn, K.A., Larson, S.M., Weissleder, R., Mankoff, D.A., Hoffman, J.M., Link, J.M., Guyton, K.Z., Eckelman, W.C., Scher, H.I., et al. (2005). The progress and promise of molecular imaging probes in oncologic drug development. Clin. Cancer Res. 11, 7967-7985.
56. Kircher, B., Stevanovic, S., Urbanek, M., Mitterschiffthaler, A., Rammensee, H.G., Grunewald, K., Gastl, G., and Nachbaur, D. (2002). Induction of HA-1-specific cytotoxic T-cell clones parallels the therapeutic effect of donor lymphocyte infusion. Br. J. Haematol. 117, 935-939.
57. Klein, C.A. and Holzel, D. (2006). Systemic cancer progression and tumor dormancy: mathematical models meet single cell genomics. Cell Cycle 5, 1788-1798.
58. Kovacs, A.F., Ghahremani, M.T., Stefenelli, U., and Bitter, K. (2003). Postoperative chemotherapy with cisplatin and 5-fluorouracil in cancer of the oral cavity and the oropharynx - long-term results. J. Chemother. 15, 495-502.
59. Kraitchman, D.L., Heldman, A.W., Atalar, E., Amado, L.C., Martin, B.J., Pittenger, M.F., Hare, J.M., and Bulte, J.W. (2003). In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 107, 2290-2293.
60. Krause, D.S., Lazarides, K., von Andrian, U.H., and Van Etten, R.A. (2006). Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nat. Med. 12, 1175-1180.
61. Kretz-Rommel, A., Qin, F., Dakappagari, N., Ravey, E.P., McWhirter, J., Oltean, D., Frederickson, S., Maruyama, T., Wild, M.A., Nolan, M.J., et al. (2007). CD200 expression on tumor cells suppresses antitumor immunity: new approaches to cancer immunotherapy. J. Immunol. 178, 5595-5605.
62. Kucia, M., Reca, R., Miekus, K., Wanzeck, J., Wojakowski, W., Janowska-Wieczorek, A., Ratajczak, J., and Ratajczak, M.Z. (2005). Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 23, 879-894.
63. Kuperwasser, C., Chavarria, T., Wu, M., Magrane, G., Gray, J.W., Carey, L., Richardson, A., and Weinberg, R.A. (2004). Reconstruction of functionally normal and malignant human breast tissues in mice. Proc. Natl. Acad. Sci. USA 101, 4966-4971.
64. Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M.A., and Dick, J.E. (1994). A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645-648.
65. Lewin, M., Carlesso, N., Tung, C.H., Tang, X.W., Cory, D., Scadden, D.T., and Weissleder, R. (2000). Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 18, 410-414.
66. Li, L. and Xie, T. (2005). Stem cell niche: structure and function. Annu. Rev. Cell. Dev. Biol. 21, 605-631.
67. Li, C., Heidt, D.G., Dalerba, P., Burant, C.F., Zhang, L., Adsay, V., Wicha, M., Clarke, M.F., and Simeone, D.M. (2007a). Identification of pancreatic cancer stem cells. Cancer Res. 67, 1030-1037.
68. Li, F., Tiede, B., Massague, J., and Kang, Y. (2007b). Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res. 17, 3-14.
69. Lichtman, M.A. (2001a). The stem cell in the pathogenesis and treatment of myelogenous leukemia: a perspective. Leukemia 15, 1489-1494.
70. Lichtman, M.A. (2001b). Chronic myelogenous leukemia and related disorders. In: Williams Hematology, 6th Edition, E. Beutler, M.A. Lichtman, T.J. Kipps, U. Seligsohn and M.H. Staff, ed. (New York, USA: McGraw-Hill), pp. 1085-1123.
71. Ling, V., Chambers, A.F., Harris, J.F., and Hill, R.P. (1984). Dynamic heterogeneity and metastasis. J. Cell. Physiol. (Suppl.) 3, 99-103.
72. + cancer stem cells in glioblastoma. Mol. Cancer 5, 67.
73. Luzzi, K.J., MacDonald, I.C., Schmidt, E.E., Kerkvliet, N., Morris, V.L., Chambers, A.F., and Groom, A.C. (1998). Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am. J. Pathol. 153, 865-873.
74. Maki, J., Masuda, C., Morikawa, S., Morita, M., Inubushi, T., Matsusue, Y., Taguchi, H., and Tooyama, I. (2007). The MR tracking of transplanted ATDC5 cells using fluorinated poly-L-lysine-CF3. Biomaterials 28, 434-440.
75. Manishen, W.J., Sivananthan, K., and Orr, F.W. (1986). Resorbing bone stimulates tumor cell growth. A role for the host microenvironment in bone metastasis. Am. J. Pathol. 123, 39-45.
76. Marijt, W.A., Heemskerk, M.H., Kloosterboer, F.M., Goulmy, E., Kester, M.G., van der Hoorn, M.A., van Luxemburg-Heys, S.A., Hoogeboom, M., Mutis, T., Drijfhout, J.W., et al. (2003). Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc. Natl. Acad. Sci. USA 100, 2742-2747.
77. Maximow, A. (1909). Der Lymphozyt als gemeinsame Stammzelle der verschieden Blutelemente in der embryonalen Entwicklung und postfetalen Leben der Säugetiere. Folia Haematol. (Leipzig) 8, 125-141.
78. Mehta, R.R., Graves, J.M., Hart, G.D., Shilkaitis, A., and Das Gupta, T.K. (1993). Growth and metastasis of human breast carcinomas with Matrigel in athymic mice. Breast Cancer Res. Treat. 25, 65-71.
79. Meng, S., Tripathy, D., Frenkel, E.P., Shete, S., Naftalis, E.Z., Huth, J.F., Beitsch, P.D., Leitch, M., Hoover, S., Euhus, D., et al. (2004). Circulating tumor cells in patients with breast cancer dormancy. Clin. Cancer Res. 10, 8152-8162.
80. Mimeault, M. and Batra, S.K. (2007). Functions of tumorigenic and migrating cancer progenitor cells in cancer progression and metastasis and their therapeutic implications. Cancer Metastasis Rev. 26, 203-214.
81. Minn, A.J., Gupta, G.P., Siegel, P.M., Bos, P.D., Shu, W., Giri, D.D., Viale, A., Olshen, A.B., Gerald, W.L., and Massague, J. (2005a). Genes that mediate breast cancer metastasis to lung. Nature 436, 518-524.
82. Minn, A.J., Kang, Y., Serganova, I., Gupta, G.P., Giri, D.D., Doubrovin, M., Ponomarev, V., Gerald, W.L., Blasberg, R., and Massague, J. (2005b). Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J. Clin. Invest. 115, 44-55.
83. Miraglia, S., Godfrey, W., Yin, A.H., Atkins, K., Warnke, R., Holden, J.T., Bray, R.A., Waller, E.K., and Buck, D.W. (1997). A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90, 5013-5021.
84. Mullen, P. (2004). The use of Matrigel to facilitate the establishment of human cancer cell lines as xenografts. Methods Mol. Med. 88, 287-292.
85. Nakanishi, J., Wada, Y., Matsumoto, K., Azuma, M., Kikuchi, K., and Ueda, S. (2007). Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers. Cancer Immunol. Immunother. 56, 1173-1182.
86. Nanda, D., de Jong, M., Vogels, R., Havenga, M., Driesse, M., Bakker, W., Bijster, M., Avezaat, C., Cox, P., Morin, K., et al. (2002). Imaging expression of adenoviral HSV1-tk suicide gene transfer using the nucleoside analogue FIRU. Eur. J. Nucl. Med. Mol. Imaging 29, 939-947.
87. Naumov, G.N., Akslen, L.A., and Folkman, J. (2006). Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch. Cell Cycle 5, 1779-1787.
88. O'Brien, C.A., Pollett, A., Gallinger, S., and Dick, J.E. (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106-110.
89. Olempska, M., Eisenach, P.A., Ammerpohl, O., Ungefroren, H., Fandrich, F., and Kalthoff, H. (2007). Detection of tumor stem cell markers in pancreatic carcinoma cell lines. Hepatobiliary Pancreat. Dis. Int. 6, 92-97.
90. Paget, S. (1889). The distribution of secondary growths in cancer of the breast. Lancet 1, 571-573.
91. Palmieri, D., Chambers, A.F., Felding-Habermann, B., Huang, S., and Steeg, P.S. (2007). The biology of metastasis to a sanctuary site. Clin. Cancer Res. 13, 1656-1662.
92. Pardal, R., Clarke, M.F., and Morrison, S.J. (2003). Applying the principles of stem-cell biology to cancer. Nat. Rev. Cancer 3, 895-902.
93. Parmar, H., Young, P., Emerman, J.T., Neve, R.M., Dairkee, S., and Cunha, G.R. (2002). A novel method for growing human breast epithelium in vivo using mouse and human mammary fibroblasts. Endocrinology 143, 4886-4896.
94. Peggs, K.S. and Mackinnon, S. (2001). Cellular therapy: donor lymphocyte infusion. Curr. Opin. Hematol. 8, 349-354.
95. Phillips, T.M., McBride, W.H., and Pajonk, F. (2006). The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J. Natl. Cancer Inst. 98, 1777-1785.
96. Plasschaert, S.L., de Bont, E.S., Boezen, M., vander Kolk, D.M., Daenen, S.M., Faber, K.N., Kamps, W.A., de Vries, E.G., and Vellenga, E. (2005). Expression of multidrug resistance-associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemia. Clin. Cancer Res. 11, 8661-8668.
97. Ponta, H., Sherman, L., and Herrlich, P.A. (2003). CD44: from adhesion molecules to signalling regulators. Nat. Rev. Mol. Cell. Biol. 4, 33-45.
98. Pratap, J., Javed, A., Languino, L.R., van Wijnen, A.J., Stein, J.L., Stein, G.S., and Lian, J.B. (2005). The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol. Cell. Biol. 25, 8581-8591.
99. Prince, M.E., Sivanandan, R., Kaczorowski, A., Wolf, G.T., Kaplan, M.J., Dalerba, P., Weissman, I.L., Clarke, M.F., and Ailles, L.E. (2007). Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 104, 973-978.
100. Rak, J. (2006). Is cancer stem cell a cell, or a multicellular unit capable of inducing angiogenesis? Med. Hypotheses 66, 601-604.
101. Ramaswamy, S., Ross, K.N., Lander, E.S., and Golub, T.R. (2003). A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33, 49-54.
102. Ray, P., De, A., Min, J.J., Tsien, R.Y., and Gambhir, S.S. (2004). Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Res. 64, 1323-1330.
103. Rodriguez, J.F., Rodriguez, D., Rodriguez, J.R., McGowan, E.B., and Esteban, M. (1988). Expression of the firefly luciferase gene in vaccinia virus: a highly sensitive gene marker to follow virus dissemination in tissues of infected animals. Proc. Natl. Acad. Sci. USA 85, 1667-1671.
104. Romero, P., Cerottini, J.C., and Speiser, D.E. (2006). The human T cell response to melanoma antigens. Adv. Immunol. 92, 187-224.
105. Schardt, J.A., Meyer, M., Hartmann, C.H., Schubert, F., Schmidt-Kittler, O., Fuhrmann, C., Polzer, B., Petronio, M., Eils, R., and Klein, C.A. (2005). Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer. Cancer Cell 8, 227-239.
106. Scherbarth, S. and Orr, F.W. (1997). Intravital videomicroscopic evidence for regulation of metastasis by the hepatic microvasculature: effects of interleukin-1a on metastasis and the location of B16F1 melanoma cell arrest. Cancer Res. 57, 4105-4110.
107. Selleri, C., Ragno, P., Ricci, P., Visconte, V., Scarpato, N., Carriero, M.V., Rotoli, B., Rossi, G., and Montuori, N. (2006). The metastasis-associated 67-kDa laminin receptor is involved in G-CSF-induced hematopoietic stem cell mobilization. Blood 108, 2476-2484.
108. Shaner, N.C., Campbell, R.E., Steinbach, P.A., Giepmans, B.N., Palmer, A.E., and Tsien, R.Y. (2004). Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat. Biotechnol. 22, 1567-1572.
109. Singh, D., Febbo, P.G., Ross, K., Jackson, D.G., Manola, J., Ladd, C., Tamayo, P., Renshaw, A.A., D'Amico, A.V., Richie, J.P., et al. (2002). Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 1, 203-209.
110. Singh, S.K., Clarke, I.D., Terasaki, M., Bonn, V.E., Hawkins, C., Squire, J., and Dirks, P.B. (2003). Identification of a cancer stem cell in human brain tumors. Cancer Res. 63, 5821-5828.
111. Singh, S.K., Clarke, I.D., Hide, T., and Dirks, P.B. (2004). Cancer stem cells in nervous system tumors. Oncogene 23, 7267-7273.
112. Sipkins, D.A., Wei, X., Wu, J.W., Runnels, J.M., Cote, D., Means, T.K., Luster, A.D., Scadden, D.T., and Lin, C.P. (2005). In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature 435, 969-973.
113. Stell, A., Belcredito, S., Ramachandran, B., Biserni, A., Rando, G., Ciana, P., and Maggi, A. (2007). Multimodality imaging: novel pharmacological applications of reporter systems. Q.J. Nucl. Med. Mol. Imaging 51, 127-138.
114. Swirski, F.K., Berger, C.R., Figueiredo, J.L., Mempel, T.R., von Andrian, U.H., Pittet, M.J., and Weissleder, R. (2007). A nearinfrared cell tracker reagent for multiscopic in vivo imaging and quantification of leukocyte immune responses. PLoS ONE 2, e1075.
115. Tacken, P.J., de Vries, I.J., Torensma, R., and Figdor, C.G. (2007). Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat. Rev. Immunol. 7, 790-802.
116. Theou, N., Gil, S., Devocelle, A., Julie, C., Lavergne-Slove, A., Beauchet, A., Callard, P., Farinotti, R., Le Cesne, A., Lemoine, A., et al. (2005). Multidrug resistance proteins in gastrointestinal stromal tumors: site-dependent expression and initial response to imatinib. Clin. Cancer Res. 11, 7593-7598.
117. Till, M.E. and McCulloch, E.A. (1961). A direct measurement of the radiosensitivity of normal mouse bone marrow cells. Radiat. Res. 14, 213-222.
118. Tjuvajev, J.G., Finn, R., Watanabe, K., Joshi, R., Oku, T., Kennedy, J., Beattie, B., Koutcher, J., Larson, S., and Blasberg, R.G. (1996). Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. Cancer Res. 56, 4087-4095.
119. Tjuvajev, J.G., Avril, N., Oku, T., Sasajima, T., Miyagawa, T., Joshi, R., Safer, M., Beattie, B., DiResta, G., Daghighian, F., et al. (1998). Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res. 58, 4333-4341.
120. Umemoto, T., Yamato, M., Nishida, K., Yang, J., Tano, Y., and Okano, T. (2006). Limbal epithelial side-population cells have stem cell-like properties, including quiescent state. Stem Cells 24, 86-94.
121. van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., and Boon, T. (1991). A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254, 1643-1647.
122. van't Veer, L.J., Dai, H., van de Vijver, M.J., He, Y.D., Hart, A.A., Mao, M., Peterse, H.L., van der Kooy, K., Marton, M.J., Witteveen, A.T., et al. (2002). Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536.
123. Wang, H.Y. and Wang, R.F. (2007). Regulatory T cells and cancer. Curr. Opin. Immunol. 19, 217-223.
124. Wang, J., Guo, L.P., Chen, L.Z., Zeng, Y.X., and Lu, S.H. (2007). Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res. 67, 3716-3724.
125. Ward, R.J. and Dirks, P.B. (2007). Cancer stem cells: at the headwaters of tumor development. Annu. Rev. Pathol. 2, 175-189.
126. Weaver, V.M., Petersen, O.W., Wang, F., Larabell, C.A., Briand, P., Damsky, C., and Bissell, M.J. (1997). Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol. 137, 231-245.
127. Weissleder, R., Tung, C.H., Mahmood, U., and Bogdanov, A., Jr. (1999). In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat. Biotechnol. 17, 375-378.
128. White, D.E., Kurpios, N.A., Zuo, D., Hassell, J.A., Blaess, S., Mueller, U., and Muller, W.J. (2004). Targeted disruption of β1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell 6, 159-170.
129. Wicha, M.S. (2006). Cancer stem cells and metastasis: lethal seeds. Clin. Cancer Res. 12, 5606-5607.
130. Wu, C.J., Biernacki, M., Kutok, J.L., Rogers, S., Chen, L., Yang, X.F., Soiffer, R.J., and Ritz, J. (2005). Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells. Clin. Cancer Res. 11, 4504-4511.
131. + glioma cells: possible targets of immunotherapy. J. Neurooncol. 83, 121-131.
132. 18F]FHBG: a reporter probe for imaging herpes simplex virus type-1 thymidine kinase reporter gene expression. J. Nucl. Med. 42, 1225-1234.
133. Yang, X.F. (2007). Immunology of stem cells and cancer stem cells. Cell. Mol. Immunol. 4, 161-171.